By now, you would literally have to be living under a rock not to be aware of the increasing interest in emergency department–initiated medication-assisted therapy (ED MAT). Programs that initiate buprenorphine while patients are still in the emergency department are popping up all over the country and have been featured in The New York Times and elsewhere, but those are still the exception and not the rule.
Explore This Issue
ACEP Now: Vol 38 – No 04 – April 2019Mid Coast Hospital is a 94-bed community hospital in Brunswick, Maine. We have a 20-bed emergency department with a three-bed ED behavioral health observation area and see about 30,000 patients annually. We are not dissimilar to any of you in terms of the impact that behavioral health emergencies, substance use, and opioid use disorder (OUD) have had on our department. At the same time that we have seen an increase in demand for substance use treatment, we seem to have experienced a decrease in community and statewide resources downstream of the emergency department.
The Mid Coast Hospital Program
In 2015, the initial D’Onofrio et al study that described ED MAT was published in JAMA. At the urging of one of our physician assistants, who was frustrated with the current state of affairs, we began to meet with our peers from the addiction resource center across town and created guidelines and protocols for ED MAT at Mid Coast Hospital. Blessed with an ED staff willing to take this on and a recovery center willing to grant quick access in follow-up, we created standard pathways so that expectations were predetermined. We provided a short educational session on buprenorphine for our ED providers. We did not require an X-waiver.
We introduced our program in the fall of 2017. It was a slow start, and we did not see very many patients the first few months. Much to everyone’s surprise, the floodgates did not open. We did not, in fact, become a substance use treatment center first and an emergency department second. Over time, however, the program took hold. Our early-adopter providers led us through the process, and now even our late adopters have begun to get involved and embrace the program.
Over the first 14 months, we initiated buprenorphine on 35 patients. Most (94 percent) of these patients arrived at their initial intake appointment, and 70 percent remain engaged in therapy at our addiction recovery center at 30 days, while others have been referred to methadone or other residential programs.
These are low-volume but high-risk and high-impact situations. Compare this to stroke. In our emergency department last year, we gave tissue plasminogen activator 15 times. Like many of you who are medical directors in emergency departments, I have spent an amazing amount of time working on systems of care for our stroke patients, with perhaps much more doubtful impact than addiction recovery can have on a life.
One of the first patients enrolled in our program was a young woman in her second trimester of pregnancy, with a 3-year-old child at home, who was using heroin daily. She remains in treatment, delivered her child, and is successfully parenting both children while holding down a job.
Another gentleman was offered the program after an opioid overdose. Like many patients after overdose, he declined treatment. However, a week later, he re-presented to the emergency department, asking for help, largely because he knew of our program.
ED MAT is based on taking advantage of an opportunity to intervene. Every day, we see patients who have either suffered an overdose, experienced a medical complication of their use, or are simply asking for help. The emergency department can extend access to treatment and relief from withdrawal 24 hours a day seven days a week. We should be positioned to seize the opportunity when it presents, as it may not present again. A request for help should be viewed as an emergency medical condition, with the proper stabilization and referral.
Even if patients are not interested in treatment at the time of their ED visit, our program sends the message that the medical system is here to help, which unfortunately is not the message that many of these patients hear in the traditional emergency department. This is a patient population that is extremely sensitive to judgment, stigma, and bias. Sometimes an eye roll or a glance at your watch is all it takes to alienate a patient, steering them from medical care. Patients who leave the emergency department should know that when and if they are ready for treatment, we are ready to assist them.
EM-Specific MAT Waiver Training Offered at LAC19
The Leadership & Advocacy Conference (LAC) is coming up May 5-8 in Washington, D.C., and it’s a great chance for emergency physicians to advocate for the profession, engage with members of Congress, and connect with other EM leaders. It’s also the first time ACEP is offering EM-specific MAT Waiver Training and the ED Acute Pain Management Bootcamp at the tail end of LAC.
Pages: 1 2 3 | Single Page
3 Responses to “ED-Initiated Medication-Assisted Therapy: 1 Hospital’s Experience”
April 21, 2019
Dr. RAThis is not an “emergency medical condition” and please remove the phrase. It is a medical condition which can be addressed and treated by emergency room staff and providers, but let’s not address it as the prior wording. A stroke, heart attack, overdose, sepsis are “emergency medical condition”s. Opiate Abuse (or OUD if preferred) is not.
That said with evidence even as powerful as the Yale study have shown, after 30 days the evidence is scarce and even with such the need for coordinated outpatient therapy is a must if ED staff is to start dispensing MAT. I agree the ED is a great place to initiate therapy, but realize the limitations placed in front of us.
April 21, 2019
sandra schneiderFirst ever EM specific MAT course will be held on May 9/10th just after the Leadership and Advocacy Course in DC. For further information, click on the Leadership and Advocacy Course and look for MAT.
April 25, 2019
Evan SchwarzGreat article. For anyone that is interested, ACEP recently endorsed ACMT’s (American College of Medical Toxicology) position statement on this.
https://www.acmt.net/_Library/Positions/ACMT_Bup_ED_Position_Statement_REV.pdf
There will also be an organized group tweet or tweet chat on May 28, 2019 at 3 pm eastern. Use #firesidetox to join in on the discussion.